84 related articles for article (PubMed ID: 35842542)
1. Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function.
Fang H; Placencio VR; DeClerck YA
J Natl Cancer Inst; 2012 Oct; 104(19):1470-84. PubMed ID: 22984202
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model.
Furuya H; Hayashi K; Shimizu Y; Kim N; Tsukikawa Y; Chen R; Sun Y; Chan OTM; Pagano I; Peres R; Hokutan K; Igari F; Chan KS; Rosser CJ
J Transl Med; 2020 Feb; 18(1):57. PubMed ID: 32024545
[TBL] [Abstract][Full Text] [Related]
3. Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer.
Murakami K; Furuya H; Hokutan K; Goodison S; Pagano I; Chen R; Shen CH; Chan MWY; Ng CF; Kobayashi T; Ogawa O; Miyake M; Thornquist M; Shimizu Y; Hayashi K; Wang Z; Yu H; Rosser CJ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902377
[TBL] [Abstract][Full Text] [Related]
4. Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors.
Wang B; Gu B; Zhang T; Li X; Wang N; Ma C; Xiang L; Wang Y; Gao L; Yu Y; Song K; He P; Wang Y; Zhu J; Chen H
Cancer Lett; 2023 Apr; 559():216117. PubMed ID: 36889376
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Salgado L; Carvalho L; Pereira D; Medeiros R
J Thromb Thrombolysis; 2024 Apr; ():. PubMed ID: 38643313
[TBL] [Abstract][Full Text] [Related]
6. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells.
Frerichs LM; Frerichs B; Petzsch P; Köhrer K; Windolf J; Bittersohl B; Hoffmann MJ; Grotheer V
Front Oncol; 2023; 13():1228185. PubMed ID: 37781195
[TBL] [Abstract][Full Text] [Related]
8. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
Sanya DRA; Onésime D
Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
[TBL] [Abstract][Full Text] [Related]
9. Effects of Nursing Care for the Treatment of Patients with Bladder Cancer: A Systematic Review and Meta-analysis.
Gao Z; Fang L; Yin P; Deng Y; Pei M; Zhou T
Comput Math Methods Med; 2022; 2022():9554223. PubMed ID: 36199769
[TBL] [Abstract][Full Text] [Related]
10. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
11. The urokinase plasminogen activator system: role in malignancy.
Duffy MJ
Curr Pharm Des; 2004; 10(1):39-49. PubMed ID: 14754404
[TBL] [Abstract][Full Text] [Related]
12. PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Furuya H; Sasaki Y; Chen R; Peres R; Hokutan K; Murakami K; Kim N; Chan OTM; Pagano I; Dyrskjøt L; Jensen JB; Malmstrom PU; Segersten U; Sun Y; Arab A; Goodarzi H; Goodison S; Rosser CJ
Sci Rep; 2022 Jul; 12(1):12186. PubMed ID: 35842542
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract][Full Text] [Related]
14. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD
Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184
[TBL] [Abstract][Full Text] [Related]
15. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
